Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validation of ICG-99mTc-nanoscan as Hybrid Tracer for Sentinel Node Biopsy (NANOSCAN)
2024-519351-28-00Phase 2Completed
- Sponsor
- Netherlands Cancer Institute
- Start
- Nov 2023
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Gamma Emitters → Radiopharmaceuticals, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of indocyanine green + technetium Tc 99m nanocolloid in cutaneous melanoma (CM), mouth cancer and penile cancer, sponsored by Netherlands Cancer Institute. Started Nov 2023; status: completed.
02
Drugs
indocyanine green + technetium Tc 99m nanocolloid
03
Conditions
cutaneous melanoma (CM)mouth cancerpenile cancer
Beyond the preview
Go deeper on 2024-519351-28-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519351-28-00.